NeuFluent is a venture studio partnering with leading innovators to accelerate breakthrough neurological technologies from concept to market.
Expertise by the numbers
$20bn+
Return on Investment
​
180+
Years of collective senior leadership
110+
Products commercialized
​
250+
Patents issued
​
25+
Exits
​
Our
initiatives
Neural intelligence across four domains
Uniting world-class teams to build breakthrough neurological technologies at scale.
Brain-Computer Interfaces
Building technologies that fundamentally change our ability to understand brain function and treat neurological disease, enabling advanced AI diagnostics and adaptive treatments that learn and respond to each patient.
Led by Dr. Samuel Browd
Led by Dr. Jeff Ojemann
Led by Dr. Dan Donoho
Led by Craig Mundie
Pharmaceutical Technology
Revolutionizing neurological treatment by engineering AI-enhanced delivery systems that bypass traditional barriers and target disease directly at its source.
Led by Dr. Russell Lonser
Intelligent Implants
& Robotics
Engineering next-generation smart implant technologies and enhanced robotic systems that transform neurological care and patient outcomes.
Led by Dr. Kevin Foley
Clinical Intelligence
Unlocking clinical insights through AI-powered technologies that transform how we diagnose, treat, and prevent neurological disease.
Led by Dr. Anthony Asher